Cochrane · systematic review · CD008331

Tocilizumab for rheumatoid arthritis

Singh, JA, Beg, S, Lopez‐Olivo, MA · Cochrane Database of Systematic Reviews · 2010 · Cochrane Library

MusculoskeletalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 1 · 14.3%Very low 0 · 0%Low 0 · 0%Moderate 2 · 28.6%High 4 · 57.1%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Tocilizumab 8 mg/kg + MTX/DMARD versus placebo + MTX/DMARD for rheumatoid arthritis

Population: patients with rheumatoid arthritis
7 questions
OutcomeEffectEvidenceStatus / GRADE
ACR50% improvement criteria
Tocilizumab 8 mg/kg + MTX/DMARD vs placebo + MTX/DMARD
RR 3.17 [2.72, 3.67]4 studies · 2063 participantsHigh
DAS Remission defined as DAS28 <2.6
Tocilizumab 8 mg/kg + MTX/DMARD vs placebo + MTX/DMARD
RR 8.74 [6.26, 11.8]4 studies · 1946 participantsHigh
HAQ improvement of >0.3 or MHAQ decrease of >0.22 (changes exceeding MCID)
Tocilizumab 8 mg/kg + MTX/DMARD vs placebo + MTX/DMARD
RR 1.79 [1.62, 1.94]1 study · 1220 participantsHigh
Serious Adverse Events
Tocilizumab 8 mg/kg + MTX/DMARD vs placebo + MTX/DMARD
RR 1.17 [0.83, 1.64]3 studies · 1961 participantsModerate
Downgraded: risk of bias, inconsistency
Total withdrawals
Tocilizumab 8 mg/kg + MTX/DMARD vs placebo + MTX/DMARD
RR 0.61 [0.49, 0.77]4 studies · 2064 participantsModerate
Downgraded: risk of bias, inconsistency
Withdrawals due to Adverse events
Tocilizumab 8 mg/kg + MTX/DMARD vs placebo + MTX/DMARD
RR 1.43 [0.95, 2.12]4 studies · 2064 participantsHigh
Radiographic Progression
Tocilizumab 8 mg/kg + MTX/DMARD vs placebo + MTX/DMARD
no estimate extracted0 studies · 4 participantsUngraded